Skip to content
10-Q

Quarterly Report

ARATANA THERAPEUTICS, INC.

0001509190-18-000044

← back to feed
Filed
Aug 3, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jul 30, 2018 47.67M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$19.4M
Operating Cash Flow Q2 2018 · Jun 30, 2017 −$29.92M
Short Term Investments Q2 2018 · Jun 30, 2018 $744K
Short Term Investments Q2 2018 · Dec 31, 2017 $747K
Cash And Equivalents Q2 2018 · Jun 30, 2018 $59.29M
Cash And Equivalents Q2 2018 · Dec 31, 2017 $66.87M
Stockholders Equity Q2 2018 · Jun 30, 2018 $93.51M
Stockholders Equity Q2 2018 · Dec 31, 2017 $80.13M
Current Liabilities Q2 2018 · Jun 30, 2018 $26.13M
Current Liabilities Q2 2018 · Dec 31, 2017 $35.5M
Total Liabilities Q2 2018 · Jun 30, 2018 $34.46M
Total Liabilities Q2 2018 · Dec 31, 2017 $55.06M
Current Assets Q2 2018 · Jun 30, 2018 $78.99M
Current Assets Q2 2018 · Dec 31, 2017 $85.24M
Total Assets Q2 2018 · Jun 30, 2018 $127.98M
Total Assets Q2 2018 · Dec 31, 2017 $135.19M
Sga Expense Q2 2018 · Jun 30, 2018 $6.71M
Sga Expense Q2 2018 · Jun 30, 2018 $14.41M
Sga Expense Q2 2018 · Jun 30, 2017 $6.92M
Sga Expense Q2 2018 · Jun 30, 2017 $14.41M
Rd Expense Q2 2018 · Jun 30, 2018 $1.58M
Rd Expense Q2 2018 · Jun 30, 2018 $3.78M
Rd Expense Q2 2018 · Jun 30, 2017 $3.7M
Rd Expense Q2 2018 · Jun 30, 2017 $8.35M
Net Income Q2 2018 · Jun 30, 2018 −$6.37M
Net Income Q2 2018 · Jun 30, 2018 −$14.92M
Net Income Q2 2018 · Jun 30, 2017 −$10.38M
Net Income Q2 2018 · Jun 30, 2017 −$22.99M
Operating Income Q2 2018 · Jun 30, 2018 −$5.73M
Operating Income Q2 2018 · Jun 30, 2018 −$13.56M
Operating Income Q2 2018 · Jun 30, 2017 −$9.59M
Operating Income Q2 2018 · Jun 30, 2017 −$21.43M
Revenue Q2 2018 · Jun 30, 2018 $4.91M
Revenue Q2 2018 · Jun 30, 2018 $8.95M
Revenue Q2 2018 · Jun 30, 2017 $5.16M
Revenue Q2 2018 · Jun 30, 2017 $8.95M
Capex Q2 2018 · Jun 30, 2017 $11K